Benzinga | Aug 3, 2021 05:32PM EDT

MiMedx Group Q2 EPS $(0.03) Beats $(0.05) Estimate, Sales $68.17M Beat $60.16M Estimate

MiMedx Group (NASDAQ:MDXG) reported quarterly losses of $(0.03) per share which beat the analyst consensus estimate of $(0.05) by 40 percent. This is a 62.5 percent increase over losses of $(0.08) per share from the same period last year. The company reported quarterly sales of $68.17 million which beat the analyst consensus estimate of $60.16 million by 13.31 percent. This is a 27.06 percent increase over sales of $53.65 million the same period last year.